Genedrive

GDR · AIM · Health Care · mcap £18m · 1.1p

Beta Briefing, track record and bull & bear case are not ready for Genedrive yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 38 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Dec 25

Source: results 30 Mar 26 ↗

Going-concern uncertainty

Revenue: £1.2m
Operating profit: −£5.4m
Net income: −£5.3m
Free cash flow: −£3.9m
Net debt: £113k
Market cap: £12.5m
EV / EBIT: –
FCF yield: −31.1%
Price / book: –

Latest half-year · H1 Dec 25 vs H1 Dec 24 results 30 Mar 26 ↗

Revenue: £570k
Operating profit: −£2.6m
Net income: −£2.4m
Cash from operations: −£1.8m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 Dec 25 (six months to 31 Dec 25), published 30 Mar 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Dec 25	FY Jun 25	FY Jun 24
Revenue	1.2	1.0	0.5
Operating profit	(5.4)	(5.4)	(5.3)
Depreciation (right-of-use)	0.0	0.0	0.2
Share-based payments	0.1	0.1	0.1
Finance costs	(0.1)	(0.1)	(2.5)
Profit before tax	(5.5)	(5.4)	(7.8)
Tax	0.2	0.2	0.7
Net income (owners)	(5.3)	(5.2)	(7.1)
EPS basic	(0.8p)	(0.9p)	(4.7p)
EPS diluted	(0.8p)	(0.9p)	(4.7p)

	H1 Dec 25	vs H1 Dec 24	H2 Jun 25	H1 Dec 24
Revenue	0.6	+63%	0.6	0.3
Operating profit	(2.6)	n/m	(2.8)	(2.6)
Depreciation (right-of-use)	0.0	n/m	0.0	0.0
Share-based payments	0.0	n/m	0.0	0.0
Finance costs	0.0	n/m	(0.1)	0.0
Profit before tax	(2.6)	n/m	(2.9)	(2.5)
Tax	0.2	−12%	(0.0)	0.2
Net income (owners)	(2.4)	n/m	(2.9)	(2.3)
EPS basic	(0.3p)	–	(0.5p)	(0.4p)
EPS diluted	(0.3p)	–	(0.5p)	(0.4p)

	LTM Dec 25	FY Jun 25	FY Jun 24
Cash from operations	(3.9)	(5.1)	(3.8)
Capex (PP&E)	(0.0)	(0.0)	(0.0)
Lease principal paid	0.0	(0.0)	(0.2)
Shares issued	2.0	1.2	6.0

	H1 Dec 25	vs H1 Dec 24	H2 Jun 25	H1 Dec 24
Cash from operations	(1.8)	n/m	(2.0)	(3.1)
Capex (PP&E)	(0.0)	n/m	(0.0)	(0.0)
Lease principal paid	0.0	n/m	0.0	(0.0)
Shares issued	0.8	n/m	1.2	0.0

	Latest Dec 25	FY Jun 25	FY Jun 24
Property, plant & equipment	0.1	0.1	0.2
Inventories	0.3	0.4	0.4
Trade receivables	0.3	0.7	0.4
Cash	0.4	1.2	5.2
Current assets	1.6	2.7	–
Total assets	1.8	2.8	6.8
Trade payables	1.7	1.4	1.4
Lease liabilities, current	–	0.0	0.0
Borrowings, non-current	0.5	0.0	–
Total liabilities	2.2	1.4	1.4
Total equity	(0.4)	1.4	5.4
Net cash / (debt) ex leases	–	1.2	5.2

	H1 Dec 25	H2 Jun 25	H1 Dec 24	H2 Jun 24
Property, plant & equipment	0.1	0.1	0.1	0.2
Inventories	0.3	0.4	0.4	0.4
Trade receivables	0.3	0.7	0.5	0.4
Cash	0.4	1.2	2.1	5.2
Current assets	1.6	2.7	3.9	–
Total assets	1.8	2.8	4.0	6.8
Trade payables	1.7	1.4	0.9	1.4
Lease liabilities, current	–	0.0	–	0.0
Borrowings, non-current	0.5	0.0	0.0	–
Total liabilities	2.2	1.4	0.9	1.4
Total equity	(0.4)	1.4	3.1	5.4
Net cash / (debt) ex leases	–	1.2	–	5.2

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.